跳至主要内容
临床试验/ITMCTR2200005889
ITMCTR2200005889尚未招募未知

China Academy of Chinese Medical Sciences Innovation Fund

China Academy of Chinese Medical Sciences Guanganmen Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • ? Patients in the active phase of ankylosing spondylitis (ASDAS-CRP=1.3) who meet the Western diagnostic criteria
  • ? Meet the diagnostic criteria of Chinese medicine evidence of ankylosing spondylitis
  • ? Age 18~65 years old.
  • ? Those who voluntarily participated in the clinical study and agreed to sign the informed consent form.

排除标准

  • ?Those who underwent AS surgery/acupuncture treatment.
  • ?Patients with other rheumatic immune diseases, such as rheumatoid Arthritis, sjogren syndrome et al.
  • ?Patients with advanced disease spinal ankylosis, severe joint deformity.
  • ?Patients with severe primary diseases such as combined tumor, severe cardiac, cerebrovascular, renal disease, liver and kidney insufficiency.
  • ?Patients with poorly controlled blood pressure, blood glucose and blood lipids.

研究者

发起方
China Academy of Chinese Medical Sciences Guanganmen Hospital

相似试验

Multicenter Real World Study of the Evaluation of... | 临床试验